Molecule.one
Molecule.one develops the Maria AI platform, which integrates frontier chemistry models with a microliter-scale high-throughput experimentation laboratory to automate drug discovery and chemical manufacturing. The company provides retrosynthesis tools, reaction-outcome prediction, and hit-to-lead acceleration services for pharmaceutical and chemical industries. Their technology utilizes agentic frameworks to generate and validate novel chemical data through autonomous research workflows.
Visit websiteWarsaw, Poland
Healthtech
Biotech
Artificial Intelligence
Pharmaceuticals
Chemistry
Funding summary
- Total raised
- €864K
- Funding rounds
- 1
Investors in Molecule.one
Investors on record for Molecule.one. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Molecule.one?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors